Study S001554

Mazdutide as Adjuvant Therapy Following Sleeve Gastrectomy in Severe Obesity:A Multicenter, Randomized, Double-Blind, Placebo-Controlled Superiority Trial

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07135141
Acronym: SMART
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: TRIPLE
Status: NOT_YET_RECRUITING
Enrollment: 256
Start: 2025-09-30
Primary completion: 2027-09-30
Lead sponsor: Beijing Friendship Hospital
Conditions: Severe Obesity
Interventions: DRUG:Sleeve gastrectomy plus early mazdutide initiation; DRUG:Sleeve gastrectomy followed with early mazdutide placebo initation
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

the rate of excess weight loss(EWL%) compared to baseline [At 48th week post procedure]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.